There are no related discussions.
Nycomed’s cancer pain drug Instanyl cleared for NHS use in Scotland
Article | 10 November 2009
Switzerland-headquartered Nycomed says it welcomes the decision by the Scottish Medicines Consortium (SMC) on Instanyl, (intranasal fentanyl), the only fast-acting intranasal treatment licensed for breakthrough cancer pain. The SMC decision means that cancer patients in Scotland will now have another option for the treatment of breakthrough cancer pain within the National Health Service in Scotland, the privately-owned drugmaker notes.
In its submission to the SMC, Nycomed estimated a net drug budget impact of £11,000 ($18,260) in year one, rising to £418,000 in year five. These figures assume some displacement of oral morphine and other fentanyl preparations, the agency noted. Given the niche position proposed, the budget impact should be less than estimated by the manufacturer as there would be no displacement of oral morphine. The manufacturer estimated eight patients would be eligible in year one rising to 309 in year five.
Enjoying this article? Have the leading Biopharma news & analysis delivered daily on email by signing up for our FREE email newsletter here.
Breakthrough cancer pain is a severe or excruciating pain of sudden onset and short duration that bursts through the background “round the clock” pain medication making management difficult. Breakthrough cancer pain, which affects up to 95% of patients with chronic cancer pain, is typically severe, sudden and brief, lasting an average of 30 minutes and striking on average four times a day.Instanyl received a European Union license in July 2009 for the treatment of breakthrough pain in adult patients already receiving maintenance opioid therapy for chronic cancer pain.
The latest discussion & debate from thepharmaletter.com discussion forums...
Gas Generators V Gas Cylinders
Peak Scientific Instruments have been established as a pioneer in Gas Generation since 1973 we are known worldwide for our excellent product range of on site gas generation
Promoting 'Safety and Efficiency in the Laboratory Environment.
Peak Scientific Instruments have a mission - to replace all cylinders. As a manufacturer of laboratory nitrogen, hydrogen & zero air gas generators they want to make everyone aware of the dangers & inconveniences of combustible gas cylinders. A Peak gas generator offers the safer solution to your gas needs by eliminating cylinders in the lab. Stop yourself worrying about the safe handling of gases, the safety valves, the explosion risk, the storage, the re-ordering & all the other things that go along with being a cylinder user - replace your cylinders with a safe, economical, endless supply of gas from a Peak generator.
Call Maureen on 0141 530 4168 or visit www.peakscientific.com
2010-01-28 09:33:10
Here just we are itroducing ourself.Barat Bioinformatics Research Institute (BBRI) is consultancy and service provider in the field of Bioinformatics and Information Technology. We aim at delivering innovative and customized Insilico solutions matched to the special needs of biotechnological and pharmaceutical origin. And we can deliever at intime datamining works.
contact
nagireddy@bbri.in visit us at www.bbri.in
2009-12-14 05:41:17
Hi all,
Apologies for the product placement here, but we just wanted to introduce ourselves. We host a lot of pharmaceutical conferences and would love to host more! If you are looking for a venue for a meeting, conference or event, Nottingham Conferences offers four flexible venues with excellent facilities, do get in touch if you are interested.
Give us a call on 0115 846 8000, visit www.nottinghamconferences.co.uk, or e-mail us at conferences@nottingham.ac.uk.
Thanks again for your time.
Kirstie
2009-12-11 11:05:02
